Ocular Surface and Anterior Segment

Areas of Expertise

  • Allergic Conjunctivitis
  • Adenoviral Conjunctivitis
  • Atopic Keratoconjunctivitis
  • Bacterial Conjunctivitis
  • Blepharitis
  • Dry Eye
  • Herpes Keratitis
  • Meibomian Gland Dysfunction
  • Neurotrophic Keratitis
  • Persistent Corneal Epithelial Defect
  • Post-Cataract Inflammation
  • Presbyobia
  • Vernal Keratoconjunctivitis

Explore how Ora is accelerating research and developing innovative products for the following indications:

Ora CAE® Dry Eye Challenge Model:
Accelerating Dry Eye Research
Learn More

Ora-CAC® Allergen Model: Advanced Research in Ocular Allergy
Learn More

Ora-NAC™ Allergen Model
Learn More

Allergen BioCube® Allergy Chamber
Learn More

Anti-inflammatory
Learn More

Over the last 40+ years, Ora has been at the forefront of supporting our customers in developing innovative products for the treatment of ocular surface disease.

We are driven to bring better research models to you, providing you with better, clearer data. The team at Ora has been instrumental in partnering with our customers to achieve 47 product approvals over the years, and has most recently supported 2 recent approvals in the treatment of dry eye disease. Our team of allergy experts has supported the clinical development of 17 anti-allergic agents for the treatment of conjunctivitis. Our experience in both experiential and environmental trials will help bring your product to market. Let’s talk about how we can successfully run your next trial!